Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Simpson

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Bone|October 19, 2019
Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysisE L Simpson, Marrissa Martyn-St James, Jean Hamilton, et al.
Pharmacoeconomics|March 21, 2013
Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisalE L Simpson, P Fitzgerald, P Evans, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2023
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progressM E Jacobson, R S Seshadri, R Morimoto, et al.
The New England Journal of Medicine|June 28, 1984
The hypercalcemia of cancer. Clinical implications and pathogenic mechanismsG R Mundy, K J Ibbotson, S M D'Souza, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 14, 2001
The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptivesA L Nightingale, R A Lawrenson, E L Simpson, et al.
The British Journal of Dermatology|July 18, 2015
Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation studyJ I Silverberg, N Patel, S Immaneni, et al.
The British Journal of Dermatology|March 31, 2015
Clearing up misunderstandings around core outcomes for atopic dermatitisH C Williams, C Apfelbacher, J R Chalmers, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2025
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?M E Jacobson, C M Boesjes, M S de Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 13, 2022
Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and AetiologyJ Ahn, D H Lee, C H Na, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trialsM E Jacobson, R S Seshadri, R Bissonnette, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Bone|October 19, 2019
Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysisE L Simpson, Marrissa Martyn-St James, Jean Hamilton, et al.
Pharmacoeconomics|March 21, 2013
Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisalE L Simpson, P Fitzgerald, P Evans, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2023
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progressM E Jacobson, R S Seshadri, R Morimoto, et al.
The New England Journal of Medicine|June 28, 1984
The hypercalcemia of cancer. Clinical implications and pathogenic mechanismsG R Mundy, K J Ibbotson, S M D'Souza, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 14, 2001
The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptivesA L Nightingale, R A Lawrenson, E L Simpson, et al.
The British Journal of Dermatology|July 18, 2015
Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation studyJ I Silverberg, N Patel, S Immaneni, et al.
The British Journal of Dermatology|March 31, 2015
Clearing up misunderstandings around core outcomes for atopic dermatitisH C Williams, C Apfelbacher, J R Chalmers, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2025
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?M E Jacobson, C M Boesjes, M S de Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 13, 2022
Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and AetiologyJ Ahn, D H Lee, C H Na, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trialsM E Jacobson, R S Seshadri, R Bissonnette, et al.
Pageof 10